Skip Navigation


Carcinogenesis Advance Access originally published online on April 11, 2003
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
24/5/817    most recent
bgg057v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Klatt, P.
Right arrow Articles by Serrano, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klatt, P.
Right arrow Articles by Serrano, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 24, No. 5, 817-826, May 2003
© 2003 Oxford University Press

COMMENTARY

Engineering cancer resistance in mice

Peter Klatt and Manuel Serrano1

Spanish National Centre of Biotechnology, Department of Immunology and Oncology, Campus de Cantoblanco, Madrid E-28049, Spain

1 To whom correspondence should be addressed Email: mserrano{at}cnb.uam.es

Research on cancer has benefited enormously from the genetic manipulation of mice. Until recently, most of the emphasis has been put on tailoring genetic alterations to accelerate tumorigenesis or to recapitulate particular aspects of the tumorigenic process. The goal of engineering mice with an increased resistance to cancer is a novel aspect that is of importance to understand cancer susceptibility and to validate therapeutic and chemopreventive strategies. Here, we review the different mouse models described to date that manifest a ‘cancer resistance’ phenotype, with a particular emphasis on the molecular basis of the resistance and on the associated phenotypes that may have a negative impact on health.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 CarcinogenesisHome page
R. Suzuki, H. Kohno, M. Suzui, N. Yoshimi, H. Tsuda, K. Wakabayashi, and T. Tanaka
An animal model for the rapid induction of tongue neoplasms in human c-Ha-ras proto-oncogene transgenic rats by 4-nitroquinoline 1-oxide: its potential use for preclinical chemoprevention studies
Carcinogenesis, March 1, 2006; 27(3): 619 - 630.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. P. Jansen, C. E. Camalier, and N. H. Colburn
Epidermal Expression of the Translation Inhibitor Programmed Cell Death 4 Suppresses Tumorigenesis
Cancer Res., July 15, 2005; 65(14): 6034 - 6041.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
C. D. Woodworth, E. Michael, L. Smith, K. Vijayachandra, A. Glick, H. Hennings, and S. H. Yuspa
Strain-dependent differences in malignant conversion of mouse skin tumors is an inherent property of the epidermal keratinocyte
Carcinogenesis, September 1, 2004; 25(9): 1771 - 1778.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
Engineering Cancer Resistance in Mice: MANUEL SERRANO, ANDER MATHEU, AND ISABEL GARCIA-CAO, Spanish National Center of Biotechnology, Campus de Cantoblanco, Madrid 28049, Spain
Toxicol Pathol, January 1, 2004; 32(1): 141 - 141.
[PDF]

Home page
 Toxicol PatholHome page
J. C.L. Schuh
Trials, Tribulations, and Trends in Tumor Modeling in Mice
Toxicol Pathol, January 1, 2004; 32(1_suppl): 53 - 66.
[Abstract] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.